Stop timing, based on medication, surgery type and your doctor
When muscle mass and loading decrease, the stimulus to maintain bone strength may decrease as well
Explore our co-located event, the Biosimilars & Innovator Biologics Summit, for more key developments
in patients with T2DM (38) found that continuous GLP-1 administration via a subcutaneous pump to raise serum GLP-1 levels from a mean of 9.7 pM at baseline to 282 pM over 6 weeks significantly reduced plasma glucose concentrations, improved glycated hemoglobin, and enhanced insulin sensitivity and -cell function compared to placebo, with no significant limiting side effects reported
Consistency is Key: Noticeable, long-term changes in firmness typically appear after about 6 weeks of consistent use
Anti-inflammatory effects of GLP-1 Beyond weight loss, GLP-1 medications directly combat joint inflammation